Brainsway's Deep TMS device gets FDA OK for depression treatment

01/10/2013 | Globes (Israel)

The FDA has cleared Brainsway's Deep TMS device for use in treating patients with depression who don't respond to drugs during an episode. The clearance paves the way for Brainsway to enter a key market in the U.S., which the firm says is worth billions of dollars per year.

View Full Article in:

Globes (Israel)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ